A Sendai virus-based expression system directs efficient induction of chondrocytes by transcription factor-mediated reprogramming.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
29 10 2024
Historique:
received: 12 06 2024
accepted: 23 10 2024
medline: 30 10 2024
pubmed: 30 10 2024
entrez: 30 10 2024
Statut: epublish

Résumé

Cartilage rarely heals spontaneously once damaged. Osteoarthritis (OA) is the most common degenerative joint disease among the elderly; however, effective treatment for OA is currently lacking. Autologous chondrocyte implantation (ACI), an innovative regenerative technology involving the implantation of healthy chondrocytes, may restore damaged lesions. Chondrocytes for ACI may potentially be induced from differentiated somatic cells using retrovirus (RV)-mediated transduction of three reprogramming factors (SOX9, KLF4, and c-MYC). However, the efficiency of the current induction system needs to be improved and the safety issues arising from the genomic integration of the vector DNA have to be addressed. To solve these problems, we used an RNA vector, termed the replication-defective and persistent Sendai virus vector (SeVdp), to express reprogramming factors for chondrocyte induction. Our results showed that the SeVdp-based vector induced chondrocytes more efficiently than the RV vector, probably because of robust and rapid expression of the transgenes, without any apparent integration of the SeVdp vector. The induced chondrocytes formed cartilage-like tissues when injected subcutaneously into mice. Thus, the SeVdp-based system for inducing chondrocytes may act as a foundation for developing safer and more effective treatments for damaged cartilage.

Identifiants

pubmed: 39472618
doi: 10.1038/s41598-024-77508-1
pii: 10.1038/s41598-024-77508-1
doi:

Substances chimiques

Kruppel-Like Factor 4 0
SOX9 Transcription Factor 0
Klf4 protein, mouse 0
Proto-Oncogene Proteins c-myc 0
Kruppel-Like Transcription Factors 0
Transcription Factors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

26004

Subventions

Organisme : Japan Society for the Promotion of Science
ID : JP19H03203
Organisme : Japan Society for the Promotion of Science
ID : JP17H04036
Organisme : Japan Society for the Promotion of Science
ID : JP19K07343
Organisme : Japan Agency for Medical Research and Development
ID : JP22ym0126803

Informations de copyright

© 2024. The Author(s).

Références

Brittberg, M. et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N. Eng. J. Med. 331, 889–895 (1994).
Peterson, L., Brittberg, M., Kiviranta, I., Åkerlund, E. L. & Lindahl, A. Autologous chondrocyte transplantation. Am. J. Sports Med. 30, 2–12 (2002).
pubmed: 11798989
Hiramatsu, K. et al. Generation of hyaline cartilaginous tissue from mouse adult dermal fibroblast culture by defined factors. J. Clin. Investig. 121, 640–657 (2011).
pubmed: 21293062 pmcid: 3026734
Outani, H. et al. Direct induction of chondrogenic cells from human dermal fibroblast culture by defined factors. PLoS ONE 8, e77365 (2013).
pubmed: 24146984 pmcid: 3797820
Sekiguchi, Y., Fukuda, A., Nishimura, K. & Hisatake, K. Engineering critical residues of SOX9 discovers a variant with potent capacity to induce chondrocytes. Stem Cells 41, 1157–1170 (2023).
pubmed: 37651107
Kurian, K. M., Watson, C. J. & Wyllie, A. H. Retroviral vectors. J. Clin. Pathol. Mol. Pathol. 53 (2000).
Chameettachal, A., Mustafa, F. & Rizvi, T. A. Understanding retroviral life cycle and its genomic RNA packaging. J. Mol. Biol. 435, 167924 (2023).
pubmed: 36535429
Li, Z. et al. Murine leukemia induced by retroviral gene marking. Science 1979(296), 497–497 (2002).
Aoi, T. et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321, 699–702 (2008).
pubmed: 18276851
Hacein-Bey-Abina, S. et al. LMO2 -associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415–419 (2003).
pubmed: 14564000
Nishimura, K. et al. Development of defective and persistent Sendai virus vector: A unique gene delivery/expression system ideal for cell reprogramming. J. Biol. Chem. 286, 4760–4771 (2011).
pubmed: 21138846
Miyamoto, K. et al. Direct in vivo reprogramming with Sendai virus vectors improves cardiac function after myocardial infarction. Cell Stem Cell 22, 91-103.e5 (2018).
pubmed: 29276141
Nishimura, K. et al. Persistent and stable gene expression by a cytoplasmic RNA replicon based on a noncytopathic variant sendai virus. J. Biol. Chem. 282, 27383–27391 (2007).
pubmed: 17623660
Benya, P. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell 30, 215–224 (1982).
pubmed: 7127471
Kustikova, O. S. et al. Dose finding with retroviral vectors: Correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population. Blood 102, 3934–3937 (2003).
pubmed: 12881303
Bloyet, L.-M. The nucleocapsid of paramyxoviruses: structure and function of an encapsidated template. Viruses 13, 2465 (2021).
pubmed: 34960734 pmcid: 8708338
Salas-Briceno, K., Zhao, W. & Ross, S. R. Murine leukemia virus infection of non-dividing dendritic cells is dependent on nucleoporins. PLoS Pathog. 20, e1011640 (2024).
pubmed: 38215165 pmcid: 10810426
Dhanasekaran, R. et al. The MYC oncogene—The grand orchestrator of cancer growth and immune evasion. Nat. Rev. Clin. Oncol. 19, 23–36 (2022).
pubmed: 34508258
He, Z., He, J. & Xie, K. KLF4 transcription factor in tumorigenesis. Cell Death Discov. 9, 118 (2023).
pubmed: 37031197 pmcid: 10082813
Horie, M. et al. Endogenous non-retroviral RNA virus elements in mammalian genomes. Nature 463, 84–87 (2010).
pubmed: 20054395 pmcid: 2818285
Horie, M. & Tomonaga, K. Non-retroviral fossils in vertebrate genomes. Viruses 3, 1836–1848 (2011).
pubmed: 22069518 pmcid: 3205384
Zhang, L. et al. Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues. Proc. Natl. Acad. Sci. USA 118, 34 (2021).
Enomoto, H. et al. Cbfa1 is a positive regulatory factor in chondrocyte maturation. J. Biol. Chem. 275, 8695–8702 (2000).
pubmed: 10722711
Oh, J.-H., Park, S.-Y., de Crombrugghe, B. & Kim, J.-E. Chondrocyte-specific ablation of Osterix leads to impaired endochondral ossification. Biochem. Biophys. Res. Commun. 418, 634–640 (2012).
pubmed: 22290230 pmcid: 4012832
Murakami, Y. et al. Newly-developed Sendai virus vector for retinal gene transfer: reduction of innate immune response via deletion of all envelope-related genes. J. Gene Med. 10, 165–176 (2008).
pubmed: 18074401
Yamaki, Y. et al. Utilization of a novel Sendai virus vector in ex vivo gene therapy for hemophilia A. Int. J. Hematol. 113, 493–499 (2021).
pubmed: 33385293
Ban, H. et al. Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. Proc. Natl. Acad. Sci. USA 108, 14234–14239 (2011).
pubmed: 21821793 pmcid: 3161531
Nishimura, K. et al. Simple and effective generation of transgene-free induced pluripotent stem cells using an auto-erasable Sendai virus vector responding to microRNA-302. Stem Cell Res. 23, 13–19 (2017).
pubmed: 28666145
Haurwitz, R. E., Jinek, M., Wiedenheft, B., Zhou, K. & Doudna, J. A. Sequence- and structure-specific RNA processing by a CRISPR endonuclease. Science 329, 1355–1358 (2010).
pubmed: 20829488 pmcid: 3133607
Kishimoto, T. et al. An engineered ligand-responsive Csy4 endoribonuclease controls transgene expression from Sendai virus vectors. J. Biol. Eng. 18, 9 (2024).
pubmed: 38229076 pmcid: 10790456
Qiu, L., Lai, W., Stumpo, D. & Blackshear, P. Mouse embryonic fibroblast cell culture and stimulation. Bio. Protoc. 6 (2016).

Auteurs

Jingwen Zhou (J)

Laboratory of Gene regulation, Institute of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.

Yuya Sekiguchi (Y)

Laboratory of Gene regulation, Institute of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.

Masayuki Sano (M)

Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Central 5, 1-1-1 Higashi, Tsukuba, Ibaraki, 305-8565, Japan.

Ken Nishimura (K)

Laboratory of Gene regulation, Institute of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.

Koji Hisatake (K)

Laboratory of Gene regulation, Institute of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan. kojihisa@md.tsukuba.ac.jp.

Aya Fukuda (A)

Laboratory of Gene regulation, Institute of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan. fukudaa@md.tsukuba.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH